In various cancer entities including medulloblastoma, the transcription factor STAT3 as downstream target of various receptor tyrosine kinases has been implicated in the regulation of cellular programs including cell-cycle progression, apoptosis, tumour angiogenesis and tumour-cell evasion of the immune system [43–47]. The gene discussed is NTRK1; the disease is neoplasm.